CIK 0001439222
- Large accelerated filer
AGIOS PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- AGIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 617-649-8600
- Business address
- 88 SIDNEY STREET, CAMBRIDGE, MA, 02139
- Former names
- AGIOS PHARMACEUTICALS INC
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Executive Officer sold 6,000 shares at $50.01 ($300,060)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Gift Chief Scientific Officer gave 7,800 shares (gift)
- 4 Open-market sale Chief Scientific Officer sold 32,500 shares at $65.00 ($2,112,500)
- 4 Open-market sale Chief Scientific Officer sold 5,000 shares at $60.00 ($300,000)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Director sold 2,504 shares at an average $48.94 ($122,546)
- 4 Open-market sale Chief Scientific Officer sold 5,000 shares at $55.00 ($275,000)
- 4 Open-market sale Director sold 2,504 shares at an average $54.08 ($135,404)
- 4 Open-market sale Chief Scientific Officer sold 5,000 shares at $50.00 ($250,000)
Page 26 of 38 · 758 filings